Acthar Gel (Repository corticotropin hormone) for Rheumatoid Arthritis

Overview
Acthar Gel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat rheumatoid arthritis. Acthar Gel is also referred to by its drug name, repository corticotropin hormone injection.

Acthar Gel is an adrenocorticotropic hormone (ACTH) analogue. Acthar Gel is believed to work by stimulating the body to produce corticosteroid hormones that help control inflammation.

How do I take it?
Prescribing information states that Acthar Gel is usually administered as a subcutaneous or intramuscular injection.

Side effects
The FDA-approved label for Acthar Gel lists common side effects including fluid retention, changes in glucose tolerance, high blood pressure, behavioral and mood changes, increased appetite, and weight gain.

Rare but serious side effects listed for Acthar Gel include adrenal insufficiency, a disorder of blood cortisol levels known as Cushing’s syndrome, stomach and intestinal damage, severe depression, psychosis, eye disorders such as glaucoma or cataracts, loss of bone density, and increased risk of infection.

For more details about this treatment, visit:

Acthar Gel — Mallinckrodt
https://www.acthar.com/acthar-patient-support

H.P. Acthar Gel — RxList
https://www.rxlist.com/hp-acthar-gel-drug.htm